Tesamorelin 5 mg research peptide vial from SilverLeaf Bio
SilverLeaf Bio Tesamorelin 5 mg research vial viewed from above
SilverLeaf Bio Tesamorelin 5 mg research vial on a kitchen countertop
SilverLeaf Bio Tesamorelin 5 mg research vial angled product view

Tesamorelin

Metabolic / Performance
GHRH Analog
GHRH • GH/IGF-1 Axis
  • Studied for GHRH receptor signaling
  • Researched for GH and IGF-1 pathway activity
  • Associated with visceral-adiposity research models
  • Used in metabolic and body-composition research
5mg

$89.99

Availability: In stock

For research purposes only.
Reconstitution Calculator
Emma Lindsay research guide in a white lab coat with a steel blue blouse

Emma Lindsay

RESEARCH GUIDE

I’ve pulled together the key product details, research context, and supporting information so you can quickly decide whether this item lines up with your research goals.

Overview

Tesamorelin is a research peptide studied for growth hormone release, visceral fat, body composition, and broader metabolic signaling. In plain English, it is designed to mimic part of the body’s natural growth hormone-releasing system, which helps researchers study how stimulating endogenous growth hormone can influence fat distribution, especially around the abdomen, as well as recovery, lipid metabolism, and related body-composition changes.

Scientifically, Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that activates the GHRH receptor and stimulates endogenous growth hormone secretion, leading to downstream IGF-1 activity. Its research profile includes GH/IGF-1 axis biology, visceral-adiposity models, lipid markers, liver-fat research, and body-composition pathways. Unlike exogenous HGH, Tesamorelin works upstream by stimulating the body’s own growth hormone release rather than directly activating the growth hormone receptor.

The Science Behind Tesamorelin
Explore how Tesamorelin is studied through GHRH signaling and the GH/IGF-1 axis.
Tesamorelin is studied as a synthetic growth hormone-releasing hormone analog, often described as a GHRH or growth hormone-releasing factor analog. Its primary research identity is tied to stimulation of GHRH receptors, which are associated with endogenous growth hormone release and downstream insulin-like growth factor-1 (IGF-1) signaling. This makes Tesamorelin different from direct growth hormone products because it is researched through the signaling system that regulates growth hormone release rather than supplying growth hormone itself.

The scientific interest around Tesamorelin comes from its role in GH/IGF-1 axis research, visceral-adiposity models, lipid metabolism, liver-fat research, and body-composition studies. Clinical research in HIV-associated lipodystrophy has examined Tesamorelin for changes in visceral adipose tissue, metabolic markers, and liver-fat biology.
Is Tesamorelin Right for Your Research Goals?
Discover how Tesamorelin fits into GH-axis research and what considerations may be important before selection.
Tesamorelin may be relevant for research goals focused on growth hormone-releasing hormone signaling, endogenous GH pulse biology, IGF-1 response, visceral-adiposity models, lipid markers, liver-fat research, and body-composition pathways. It may be especially useful when the research goal is to study the GH/IGF-1 axis through a GHRH analog rather than through direct somatropin exposure or ghrelin-receptor secretagogue activity. This gives Tesamorelin a distinct place within growth hormone axis research.

Tesamorelin also requires careful research-context consideration. Clinical label information for approved tesamorelin medicines includes contraindications involving disruption of the hypothalamic-pituitary axis, active malignancy, known hypersensitivity, and pregnancy. Research contexts involving a history of malignancy, elevated IGF-1, glucose intolerance or diabetes, diabetic retinopathy concerns, fluid retention, edema, arthralgia, carpal tunnel-type symptoms, acute critical illness, pediatric growth-plate concerns, pregnancy or breastfeeding, and hypersensitivity reactions deserve additional caution and professional review.
Dosage, Reconstitution & Storage
General clinical-reference dosing, reconstitution, handling, and storage information to help maintain peptide integrity.
Clinical-reference Tesamorelin labeling uses daily subcutaneous study exposure, with historical 1 mg vial formulations commonly referenced at 2 mg once daily, EGRIFTA SV referenced at 1.4 mg once daily, and EGRIFTA WR referenced at 1.28 mg once daily. Published clinical research has commonly examined Tesamorelin over 26-week and 52-week windows in HIV-associated lipodystrophy and visceral-adiposity research. Researcher-reported exploratory ranges often cluster around 1-2 mg per day or 5-7 days per week, sometimes structured around multi-month research windows. These ranges should be understood as research-context references only. Protocol design depends on the study model, concentration, GH/IGF-1 monitoring approach, metabolic endpoint, and safety controls.

For storage and handling, Tesamorelin should follow standard peptide-integrity practices. Store unopened lyophilized vials refrigerated when possible and protected from direct light, heat, and repeated temperature changes. Once reconstituted, keep refrigerated unless a specific validated formulation states otherwise, avoid unnecessary warming, freezing, or repeated agitation, and protect from light. If mixing is needed after adding diluent, gently swirl the vial rather than shaking it. Aggressive shaking can create foaming and may reduce peptide integrity over time.
-SILVERLEAF MULTI-BUY OFFER-

BUY 4.
GET 1 FREE.

Add any 5 eligible peptides to your cart. The lowest-priced item is automatically free.

No coupon code required.

Researched in Combination With Tesamorelin

SilverLeaf Bio CJC-1295 + Ipamorelin 10 mg research vial front view
CJC-1295 + Ipamorelin
10mg
$84.99
HGH 10 IU research peptide vial from SilverLeaf Bio
Human Growth Hormone (HGH)
10 IU
$119.99
IGF-1 LR3 1 mg research peptide vial from SilverLeaf Bio
IGF-1 LR3
1mg
$89.99
SilverLeaf Bio AOD-9604 5 mg research vial front view
AOD-9604
5mg
$74.99

Research Guides & Resources

Canadian couple using Shakepay to make a Bitcoin payment

How to Pay With Bitcoin in Canada

Follow a simple step-by-step guide to buying Bitcoin in Canada and completing your SilverLeaf Bio order securely.

READ article
Laboratory bench with pipettes, sample tubes, assay plate, and research equipment for peptide research methods

Peptide Research Beginner’s Guide

Learn the basics of peptide research, including reconstitution, measurement, handling, record-keeping, and good research practices.

READ article

Questions About This Peptide?

Meet NOVA — Your AI Research Assistant

Get instant answers about peptide biology, research applications, storage requirements, research pairings, shipping details, and more.

  • What does this peptide do?
  • Is it right for my needs?
  • What can it be stacked with?
  • How do I store it/ reconstitute it?
  • How long does shipping take?
ASK NOVA

Trained on SilverLeaf Bio product information, educational resources, and research content.

Third-Party Tested

Quality you can trust.

FREE Shipping

On all Orders over $300

Earn Rewards

Collect points on every purchase

Canadian Focused

Family Owned & Operated

Shopping Cart
Ask Nova Ask Nova